research compound comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-08-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
== Teams == For the 2019 season the following teams were not listed by the UCI at UCI Women's team level: Alasayl Cycling Team, Cylance Pro Cycling, Experza–Footlogix, S.C. Michela Fanini Rox, Storey Racing, UnitedHealthcare and Wiggle High5.
taxis A directional response by a cell or a population of cells to a specific stimulus; a movement or other activity occurring in a non-random direction and dependent on the direction from which the stimulus originated. This contrasts with kinesis, a response without directional bias.
87 Tobias Kamke, his semifinal opponent No. 56 Andrey Golubev, and his final opponent No. 89 Paul-Henri Mathieu. At the age of 17 years and 2 months, he became the youngest player to win a Challenger title since Bernard Tomic in 2009 and the twelfth youngest in history. Zverev followed up this title with a breakthrough at the ATP Tour level. He entered the International German Open having never won an ATP match but managed to reach the semifinals. He recorded four match wins at the event, including his first career victory against Robin Haase and his first top 20 victory over No. 16 Mikhail Youzhny before losing to No. 7 David Ferrer. He became the first 17-year old to defeat a top 20 opponent since Richard Gasquet in 2004 and the first to make a semifinal since Marin Čilić in 2006. Zverev had risen from No. 665 to No. 285 after his Challenger title, and his ATP 500 Series semifinal appearance took him to No. 161 in the world. He finished the season ranked No. 136.
Cossacks served as border guards and protectors of towns, forts, settlements, and trading posts. They performed policing functions on the frontiers, and also came to represent an integral part of the Russian army. In the 16th century, to protect the borderland area from Tatar invasions, Cossacks carried out sentry and patrol duties, guarding against Crimean Tatars and nomads of the Nogai Horde in the steppe region.
=== Genome === As of early 2022, about 7 million SARS-CoV-2 genomes had been sequenced and deposited into public databases and another 800,000 or so were added each month. By September 2023, the GISAID EpiCoV database contained more than 16 million genome sequences. SARS-CoV-2 has a linear, positive-sense, single-stranded RNA genome about 30,000 bases long. Its genome has a bias against cytosine (C) and guanine (G) nucleotides, like other coronaviruses. The genome has the highest composition of U (uracil) (32.2%), followed by A (adenine) (29.9%), and a similar composition of G (19.6%) and C (18.3%). The nucleotide bias arises from the mutation of guanines and cytosines to adenines and uracils, respectively. The mutation of CG dinucleotides is thought to arise to avoid the zinc finger antiviral protein related defence mechanism of cells, and to lower the energy to unbind the genome during replication and translation (adenine and uracil base pair via two hydrogen bonds, cytosine and guanine via three). The depletion of CG dinucleotides in its genome has led the virus to have a noticeable codon usage bias. For instance, arginine's six different codons have a relative synonymous codon usage of AGA (2.67), CGU (1.46), AGG (.81), CGC (.58), CGA (.29), and CGG (.19). A similar codon usage bias trend is seen in other SARS–related coronaviruses.
Sources: en.wikipedia.org
== Management == Currently, the only treatment for coeliac disease is a lifelong gluten-free diet (GFD). Current guidelines recommend regular follow-up doctor's appointments, monitoring the disease activity, preventative care, and consultation with a dietitian.
Basement membranes are characteristic of eumetazoans, including diploblastic animals, and have also been identified in homoscleromorph sponges. The homoscleromorph were found to be sister to diploblasts in some studies, making the membrane originate once in the history of life. But more recent studies have disregarded diploblast-homoscleromorph group, so other sponges may have lost it (most probable) or the origin in the two groups may be separate.
In their discovery of elements 99 and 100, the American teams had competed with a group at the Nobel Institute for Physics, Stockholm, Sweden. In late 1953 to early 1954, the Swedish group succeeded in synthesizing light isotopes of element 100, in particular 250Fm, by bombarding uranium with oxygen nuclei. These results were also published in 1954. Nevertheless, the priority of the Berkeley team was generally recognized, as its publications preceded the Swedish article, and they were based on the previously undisclosed results of the 1952 thermonuclear explosion; thus the Berkeley team was given the privilege to name the new elements. As the effort which had led to the design of Ivy Mike was codenamed Project PANDA, element 99 had been jokingly nicknamed "Pandemonium" but the official names suggested by the Berkeley group derived from two prominent scientists, Einstein and Fermi: "We suggest for the name for the element with the atomic number 99, einsteinium (symbol E) after Albert Einstein and for the name for the element with atomic number 100, fermium (symbol Fm), after Enrico Fermi." Both Einstein and Fermi died between the time the names were originally proposed and when they were announced. The discovery of these new elements was announced by Albert Ghiorso at the first Geneva Atomic Conference held on 8–20 August 1955. The symbol for einsteinium was first given as "E" and later changed to "Es" by IUPAC.
The Austrian public radio station Ö1 Kulturmagazin drew parallels to Kermani's earlier works, noting that its comparative religious metaphysics were also influenced by the question of theodicy. Kermani received the Joseph Breitbach Prize in 2014 for his book Dein Name [Your Name]. and the Thomas Mann Prize in 2024 for his novel Das Alphabet bis S [The Alphabet up to S], which in form and content is a sequel to Dein Name. Advocating for the ideological neutrality of the state Kermani nevertheless criticizes "religious illiteracy" associated with the "complete suppression of religion", which he says leads to a "fundamental spiritual impoverishment of society". Identifying religious tolerance and freedom of religion as important European values, Kermani emphatically calls for the consideration of the beliefs and worldviews of others in the spirit of the Enlightenment. No human being can uncover the ultimate mysteries such as why something exists rather than nothing. According to Kermani, that is why religion came into being in the first place: in it, humans find ways of dealing with what they cannot explain. Religion, then, does not run contrary to the Enlightenment; rather, religion gives expression to what transcends human reason. Kermani notes that precisely to ignore the limits of human reason is what actually constitutes a more anti-Enlightenment stance.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.